We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs@K5Global and others. 🧠🧠
Read the release:
https://t.co/0spN7uh9WZ
Excited to share we made the @FastCompany Most Innovative Companies 2026 list in the Data Science category. 🔥🔥🔥
View the list: https://t.co/iqOJwJv04N
#FCMostInnovative#BCI
Neuralink rival company @synchroninc just raised $200 million.
Their CEO @tomoxl joined TITV to explain his plans.
Watch the full episode: https://t.co/bAdl9nQxbH
Company targets pivotal trials of brain-computer interface platform that allows control of digital devices using thought alone.
https://t.co/O2Lq8GhNrD
#neurotech#longevity#investment#BCI#technology
We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs@K5Global and others. 🧠🧠
Read the release:
https://t.co/0spN7uh9WZ
Markets eye a potential tariff rollback while Evommune and @Aeromexico will make their Wall Street debuts on the NYSE. Elsewhere, @synchroninc announces it raised $200 Million in Series D funding. @Ash_TV has more in the market update.
➡️ Follow @NYSE for the daily Market Update
We’re excited to return as exhibitors at #ALSNexus2025, hosted by @alsassociation, an event where leaders across research, care, and advocacy come together to drive progress for the #ALS community.
Meet us at Booth #102.
More info: https://t.co/kuFiRHGEXI
During @theCUBE + @NYSE Wired: Medtech Unplugged Series, @dvellante spoke to @KurtHaggstrom about @Synchroninc’s Brain Computer Interface (BCI) & how it’s less invasive, & more scalable & durable than Neuralink.
💡 More insights:
https://t.co/ftiF5SaUWg
@furrier@bjbaumann2014
Synchron combines brain implant with @Apple's BCI protocol to enable control of consumer electronic devices via neural signals.
https://t.co/2cG6QPXYDp
#longevity#neurotech#BCI#iPad#ALS
You can officially control an Apple device with your thoughts, as long as you have the Stentrode brain implant made by NYC-based Synchron.
https://t.co/SSly9RR77k
Apple's new thought control protocol has now been shown in use by Synchron, a medical company that has made a prototype for using iPads solely by thinking. By @WGallagher
https://t.co/Simwvv07VP
Synchron is the first company to connect its brain-computer interfaces to Apple products, and a video shows it in action for the first time—with one innovative new feature we didn't expect. https://t.co/88FSFLrgaM